News Press Releases

25 Stocks Moving In Friday's Pre-Market Session

GERN, ONTO, OMEX, GDOT | March 23, 2018

Gainers
‎

SMART Global Holdings, Inc. (NYSE: SGH) shares rose 10.9 percent to $48.85 in pre-market trading after the company reported upbeat results for its second quarter and issued strong outlook for the third quarter.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) shares rose 10.3 percent to $2.68 in pre-market trading after the company won patent eligibility ruling against Oxford Nanopore.
Cronos Group Inc. (NASDAQ: CRON) rose 8.3 percent to $8.00 in pre-market trading after declining 3.21 percent on Thursday.
Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) shares rose 5.5 percent to $22.50 in pre-market trading after climbing 18.16 percent on Thursday.
Cleveland-Cliffs Inc. (NYSE: CLF) rose 5.1 percent to $7 in pre-market trading after falling 9.14 percent on Thursday.
NIKE, Inc. (NYSE: NKE) rose 5 percent to $67.60 in pre-market trading after the company reported stronger-than-expected results for its third quarter and reported the purchase of Zodiac.
SSLJ.com Limited (NASDAQ: SSLJ) rose 4.6 percent to $5.45 in pre-market trading after climbing 7.42 percent on Thursday.
Geron Corporation (NASDAQ: GERN) shares rose 4.5 percent to $5.50 in pre-market trading after surging 5.41 percent on Thursday.
Nanometrics Incorporated (NASDAQ: NANO) shares rose 4.5 percent to $31.00 in pre-market trading after declining 2.11 percent on Thursday.
GlaxoSmithKline plc (NYSE: GSK) shares rose 4.2 percent to $37.67 in the pre-market trading session. GlaxsoSmithKline did not submit final bid for Pfizer's consumer healthcare unit, Reuters reported.
Just Energy Group Inc. (NYSE: JE) rose 4 percent to $4.67 in pre-market trading after dropping 2.18 percent on Thursday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) fell 18.1 percent to $6.85 in pre-market trading after the FDA extended review of New Drug Application for AZEDRA by three months.
Avon Products, Inc. (NYSE: AVP) fell 10.6 percent to $2.53 after declining 3.41 percent on Thursday.
Akebia Therapeutics, Inc. (NASDAQ: AKBA) shares fell 10.5 percent to $10.46 in pre-market trading after the company reported a $85 million common stock offering.
Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) fell 7.8 percent to $7.65 in pre-market trading after climbing 118.42 percent on Thursday.
Nxt-ID, Inc. (NASDAQ: NXTD) fell 9.4 percent to $2.03 in the pre-market trading session after dropping 3.86 percent on Thursday.
Leap Therapeutics, Inc. (NASDAQ: LPTX) shares fell 9 percent to $7.47 in pre-market trading after the company disclosed a proposed common stock offering.
Paycom Software, Inc. (NASDAQ: PAYC) fell 8.2 percent to $101.73 in pre-market trading. Stifel Nicolaus downgraded Paycom Software from Buy to Hold..
Resonant Inc. (NASDAQ: RESN) fell 7 percent to $3.51 in pre-market trading. Resonant priced its 5.7 million share offering at $3.50 per share.
PPDAI Group Inc. (NYSE: PPDF) shares fell 5.9 percent to $7.53 in pre-market trading after declining 2.08 percent on Thursday.
FMC Corporation (NYSE: FMC) fell 5.5 percent to $73.11 in pre-market trading after declining 3.72 percent on Thursday.
Green Dot Corporation (NYSE: GDOT) shares fell 5.5 percent to $61.48 in pre-market trading after dropping 2.61 percent on Thursday.
Citizens Financial Group, Inc. (NYSE: CFG) fell 5.3 percent to $40.69 in pre-market trading. Citizens Financial is expected to release Q1 earnings on April 20.
Editas Medicine, Inc. (NASDAQ: EDIT) shares fell 5.3 percent to $36 in pre-market trading after declining 3.16 percent on Thursday.
Micron Technology, Inc. (NASDAQ: MU) fell 3.3 percent to $56.98 in pre-market trading. Micron reported better-than-expected earnings for its second quarter and issued strong forecast for the current quarter.